Navigation Links
Revolutionary 'metamaterial' has potential to reshape neurosurgery
Date:4/25/2014

to light input.

In addition, graphene has very high electrical conductivity, as well as a high surface area allowing "efficient bioconjugation" with common biomolecules. A few years ago, graphene was one of the most expensive materials on Earth. However, as industrial production increases, it is dropping rapidly in price.

Graphene is being developed for use in a wide range of technologies, such as flexible liquid crystal displays and electronic devices, new types of integrated electric circuits, and lithium-ion microbatteriesto name just a few. It also has great promise for use in various types of biomedical devices, several of which are relevant to conditions treated by neurosurgeons.

With Many Promising Applications in Neurosurgery

Mattei and Rehman discuss some of the frontline scientific research being done to explore the capabilities and potential uses of graphene. As development continues, graphene-based metamaterials could contribute to advances in several areas of neurosurgery, including:

  • Cancer Treatment. Graphene nanoparticles may play a role in tumor-targeted imaging, as well as possible new therapeutic approaches involving photothermal or alternating electrical field stimulation therapies.

  • Intensive Care Unit Monitoring. New electrochemical and optical biosensors may provide new approaches to neurologic monitoring in patients with stroke or traumatic brain injury.

  • Neuroregeneration. Graphene materials may be used in new strategies to promote regeneration of nervous system tissuesfor example, graphene-coated scaffolds to stimulate growth of injured peripheral nerves.

  • Functional Neurosurgery. Improved electrophysiological monitoring systems may help in performing precisely targeted brain surgeries in patients with conditions such as epilepsy and movement disorders.

  • Spinal Surgery. High-resistance graphene-based hardware may represent the next generation in instrumentatio
    '/>"/>

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Moffitt instrumental in FDA approval of revolutionary 2-drug combo to treat advanced melanoma
2. SckoonCup Research Shows Revolutionary Trend in Feminine Care - Women Seek Healthier Alternatives to Tampons as Use of Menstrual Cups Soar 500%
3. Celebrity Trainer Launches Revolutionary Mind & Body Fitness Program
4. Revolutionary Dermapen Skin Resurfacing Treatment Launched In Philadelphia
5. National Energy Technologies Announces the Addition of a Revolutionary New Efficient Motor
6. Dr. Kanani, the Top Dentist in Woodland Hills Unveils How He Performs His Revolutionary Technique of Inserting Dental Implants
7. Renown Woodland Hills Dentist Unveils His Revolutionary Technique of Inserting Dental Implants
8. DYLN Inspired's Activewear Sets the New Standard For Sports Apparel With Its Revolutionary Living Fabric Technology
9. A New Revolutionary Fitness App
10. Sikka Crosses Ten Thousand Installations of its Revolutionary Cloud Optimizer Platform in Dental, Audiology, Veterinary, Small Business and Optometry Markets
11. The 3 Week Diet Review Reveals Brian Flatt's New Revolutionary Diet System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 Shriners Hospitals ... that will change the current location of Shriners Hospitals ... South Limestone across from the University of Kentucky Albert ... state-of-the-art ambulatory care center, owned and operated by Shriners ... orthopaedic needs of children and their families well into ...
(Date:10/22/2014)... October 22, 2014 Hay House is pleased ... Addiction and Upgrade Your Life (Paperback; $10.82) written by the ... & Recovery. This book is meant to help readers ... life of recovery. , Recovery 2.0 is not the ... Recovery 2.0 is a guide for what comes next. ...
(Date:10/22/2014)... During the Western United States’ worst ever ... low, Southern Oregon’s water is proving resistant to drought ... mountain snow pack on record in 2014, remain high ... That was the observation of journalist-hikers Art Bernstein and ... Oregon,” during an interview with water advocate Sharon Kleyne.† ...
(Date:10/22/2014)... Texas (PRWEB) October 22, 2014 ... of completing their continuing education at home or ... have access to 20 brand new, premium Seminar-on-Demand ... robust catalog of over 2,000 hours ... fully customize their educational experience. With such a ...
(Date:10/22/2014)... there are only 24 hours in a day, that doesn’t seem ... time within their busy schedules for exercise and fitness. Fortunately, one ... get in shape. Here are five ways you can reach your ... Up Your Commute , Consider riding a bike or taking the ... daily routine. If you must use your car to get to ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2
... & Ellis Company on REIT,s Growth Strategies, SANTA ANA, ... announced that Scott D. Peters will continue to serve as,Chairman ... Grubb &,Ellis Healthcare REIT following his resignation as Chief Executive ... am excited to be able to devote a greater degree ...
... study finds , , FRIDAY, July 11 (HealthDay News) -- People ... taking beta blockers should be kept on those medications while ... they weren,t taking beta blockers already, most of them should ... a report in the July 15 issue of the ...
... $850 million in cuts, WASHINGTON, July 11 ... important benefits and pay more out of,pocket for ... Medicare,Advantage plan altogether under legislation approved this week ... would cut nearly $14 billion from the,Medicare Advantage ...
... alcohol use, or binge drinking, among college students in the ... That is one of the key findings from research conducted ... Alcohol Study (CAS), a landmark study that surveyed more than ... a new review that examines the findings from the CAS ...
... Funds dedicated to Nursing,Homes, NEW YORK, July 11 ... mixed results and promising signs among state,government efforts to ... report, only four states spent more than 50 percent ... and community,based services. In New York State, 74% of ...
... Four Dogs Die of Cancer ... 2 MAF Canine Cancer Campaign Seeking ... and lovers in the United,States view canine cancer as the greatest health ... of cancer. Cancer is the,number one cause of death in dogs over ...
Cached Medicine News:Health News:Scott D. Peters to Continue as Chairman and CEO of Grubb & Ellis Healthcare REIT 2Health News:Scott D. Peters to Continue as Chairman and CEO of Grubb & Ellis Healthcare REIT 3Health News:Beta Blockers Help Hospitalized Heart Failure Patients 2Health News:Pennsylvania Seniors' Medicare Advantage Benefits at Risk 2Health News:Binge drinking tied to conditions in the college environment 2Health News:Binge drinking tied to conditions in the college environment 3Health News:New AARP Report Finds Mixed Results Among State Governments' Efforts to Balance Long Term Care Services Under Medicaid 2Health News:New AARP Report Finds Mixed Results Among State Governments' Efforts to Balance Long Term Care Services Under Medicaid 3Health News:Canine Cancer #1 Fear of Dog Lovers; Web Exclusive By Morris Animal Foundation Provides News on Latest Breakthroughs - Crucial Facts for Dog Owners 2
(Date:10/22/2014)... AUSTIN, Texas , Oct. 22, 2014 ... announced they have entered into a license and ... to target cancers. PhosImmune possesses technology ... the surfaces of tumor cells in association with ... from proteins that play a role in malignancy, ...
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
(Date:10/20/2014)... , Oct. 20, 2014  Indianapolis interventional medical ... Toronto -based 3D visualization leader ... of Neurological Surgeons Annual Meeting that they have ... brain surgery. The collaboration is the first of ... to improve patient outcomes. NICO,s BrainPath® interventional access ...
Breaking Medicine Technology:Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5
... Pharmaceuticals, Inc., (NASDAQ: ACRX ) ("AcelRx"), a ... of innovative therapies for the treatment of acute and ... patent granted by the European Patent Office expired on ... that the patent has been opposed. The patent (European ...
... China, May 9, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ... a leading pharmaceutical company specializing in the development, manufacturing, ... announced today that the Company filed its annual report ... 2010 with the Securities and Exchange Commission on May ...
Cached Medicine Technology:AcelRx European Patent Covering its NanoTab® Sublingual Delivery Technology for Acute and Breakthrough Pain Pipeline Products Emerges From Opposition Period 2AcelRx European Patent Covering its NanoTab® Sublingual Delivery Technology for Acute and Breakthrough Pain Pipeline Products Emerges From Opposition Period 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: